Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP)

被引:51
作者
Worley, JR
Thompkins, PB
Lee, MH
Hutton, M
Soloway, P
Edwards, DR
Murphy, G
Knäuper, V
机构
[1] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England
[2] Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England
[3] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA
关键词
activation; murine tissue inhibitor of metalloproteinases; 4 (TIMP-4); site-directed mutagenesis; trimolecular complex;
D O I
10.1042/BJ20021573
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fundamental cellular processes including angiogenesis and cell migration require a proteolytic cascade driven by interactions of membrane-type matrix metalloproteinase 1 (MT1-MMP) and progelatinase A (proMMP-2) that are dependent on the presence of tissue inhibitor of metalloproteinases 2 (TIMP-2). There are unique interactions between TIMP-2 and MT1-MMP, which we have previously defined, and here we identify TIMP-2 sequence motifs specific for proMMP-2 binding in the context of its activation by MT1-MMP. A TIMP-2 mutant encoding the C-terminal domain of TIMP-4 showed loss of proMMP-2 activation, indicating that the C-terminal domain of TIMP-2 is important in establishing the trimolecular complex between MT1-MMP, TIMP-2 and proMMP-2. This was confirmed by analysis of a TIMP-4 mutant encoding the C-terminal domain of TIMP-2, which formed a trimolecular complex andpromoted proMMP-2 processing to the intermediate form. Mutants encoding TIMP-4 from Cys(1) to Leu(185) and partial tail sequence of TIMP-2 showed some gain of activating capability relative to TIMP-4. The identified residues were subsequently mutated in TIMP-2 (E-192-D-193 to I-192-Q(193)) and this inhibitor showed a significantly reduced ability to facilitate proMMP-2 processing by MT1-MMP. Furthermore, the tail-deletion mutant Delta(186)-194TIMP-2 was completely incapable of promoting proMMP-2 activation by MT1-MMP. Thus the C-terminal tail residues of TIMP-2 are important determinants for stable trimolecular complex formation between TIMP-2, proMMP-2 and MT1-MMP and play an important role in MT1-MMP-mediated processing to the intermediate and final active forms of MMP-2 at the cell surface.
引用
收藏
页码:799 / 809
页数:11
相关论文
共 40 条
[31]   Identification of the tissue inhibitor of metalloproteinases-2 (TIMP-2) binding site on the hemopexin carboxyl domain of human gelatinase a by site-directed mutagenesis - The hierarchical role in binding TIMP-2 of the unique cationic clusters of hemopexin modules III and IV [J].
Overall, CM ;
King, AE ;
Sam, DK ;
Ong, AD ;
Lau, TTY ;
Wallon, UM ;
DeClerck, YA ;
Atherstone, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (07) :4421-4429
[32]   A MATRIX METALLOPROTEINASE EXPRESSED ON THE SURFACE OF INVASIVE TUMOR-CELLS [J].
SATO, H ;
TAKINO, T ;
OKADA, Y ;
CAO, J ;
SHINAGAWA, A ;
YAMAMOTO, E ;
SEIKI, M .
NATURE, 1994, 370 (6484) :61-65
[33]   MECHANISM OF CELL-SURFACE ACTIVATION OF 72-KDA TYPE-IV COLLAGENASE - ISOLATION OF THE ACTIVATED FORM OF THE MEMBRANE METALLOPROTEASE [J].
STRONGIN, AY ;
COLLIER, I ;
BANNIKOV, G ;
MARMER, BL ;
GRANT, GA ;
GOLDBERG, GI .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (10) :5331-5338
[34]   Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (membrane type 1)-MMP-dependent activation of pro-MMP-2 [J].
Toth, M ;
Bernardo, MM ;
Gervasi, DC ;
Soloway, PD ;
Wang, ZP ;
Bigg, HF ;
Overall, CM ;
DeClerck, YA ;
Tschesche, H ;
Cher, ML ;
Brown, S ;
Mobashery, S ;
Fridman, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (52) :41415-41423
[35]   TIMP-2 is required for efficient activation of proMMP-2 in vivo [J].
Wang, ZP ;
Juttermann, R ;
Soloway, PD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (34) :26411-26415
[36]   TISSUE INHIBITOR OF METALLOPROTEINASES-2 INHIBITS THE ACTIVATION OF 72 KDA PROGELATINASE BY FIBROBLAST MEMBRANES [J].
WARD, RV ;
ATKINSON, SJ ;
SLOCOMBE, PM ;
DOCHERTY, AJP ;
REYNOLDS, JJ ;
MURPHY, G .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1079 (02) :242-246
[37]   THE ACTIVITY OF THE TISSUE INHIBITORS OF METALLOPROTEINASES IS REGULATED BY C-TERMINAL DOMAIN INTERACTIONS - A KINETIC-ANALYSIS OF THE INHIBITION OF GELATINASE-A [J].
WILLENBROCK, F ;
CRABBE, T ;
SLOCOMBE, PM ;
SUTTON, CW ;
DOCHERTY, AJP ;
COCKETT, MI ;
OSHEA, M ;
BROCKLEHURST, K ;
PHILLIPS, IR ;
MURPHY, G .
BIOCHEMISTRY, 1993, 32 (16) :4330-4337
[38]   FOLDING AND STABILITY OF THE ACTIVE N-TERMINAL DOMAIN OF TISSUE INHIBITOR OF METALLOPROTEINASE-1 AND METALLOPROTEINASE-2 [J].
WILLIAMSON, RA ;
BARTELS, H ;
MURPHY, G ;
FREEDMAN, RB .
PROTEIN ENGINEERING, 1994, 7 (08) :1035-1040
[39]   Chemically and conformationally authentic active domain of human tissue inhibitor of metalloproteinases-2 refolded from bacterial inclusion bodies [J].
Williamson, RA ;
Natalia, D ;
Gee, CK ;
Murphy, G ;
Carr, MD ;
Freedman, RB .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 241 (02) :476-483
[40]   Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I [J].
Zhou, ZJ ;
Apte, SS ;
Soininen, R ;
Cao, RH ;
Baaklini, GY ;
Rauser, RW ;
Wang, JM ;
Cao, YH ;
Tryggvason, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (08) :4052-4057